Disclosure Panels Details Page
Acute Lymphoblastic Leukemia Panel - Disclosures as of 04/25/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Ramzi Abboud MD | Incyte Corporation | Expert Witness | None | None | 11/21/2023 |
| Peter Abdelmessieh DO,MSc | None | Bristol Myers Squibb CTI BioPharma Corp. |
None | None | 09/15/2023 |
| Ibrahim Aldoss MD | NA | NA | NA | NA | Pending |
| Ajibola Awotiwon MBBS,MSc | None | None | None | None | 12/12/2023 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Patrick Burke MD | None | None | None | None | 03/28/2024 |
| Weina Chen PhD,MD | None | None | None | None | 03/27/2024 |
| Daniel DeAngelo PhD,MD | AbbVie, Inc. Amgen Inc. Autolus Blueprint Medicines Curis Daiichi- Sankyo Co. GlycoMimetics, Inc. Jazz Pharmaceuticals Inc. Kite Pharma Mt Sinai MPN Consortium Novartis Pharmaceuticals Corporation Servier |
None | None | None | 04/14/2024 |
| Shira Dinner MD | AstraZeneca Pharmaceuticals LP Cellectis FORMA Gilead Sciences, Inc. MEI Pharma Inc. Novartis Pharmaceuticals Corporation |
Bristol Myers Squibb Kite Pharma Novartis Pharmaceuticals Corporation Pfizer Inc. Rigel Servier |
None | None | 02/23/2024 |
| Mary Dwyer MS | None | None | None | None | 02/12/2024 |
| Amir Fathi MD | AbbVie, Inc. Bristol Myers Squibb Servier |
AbbVie, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Daiichi- Sankyo Co. Genentech, Inc. Gilead Sciences, Inc. Ipsen Menarini Pfizer Inc. Remix Rigel Schrodinger Ing REG SHS Servier Pharmaceuticals Syndax Takeda Pharmaceuticals North America, Inc. |
None | None | 02/26/2024 |
| Meghan Fay OCN,RN,BSN | None | None | None | None | 01/10/2024 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 04/22/2024 |
| Jordan Gauthier MSc,MD | Angiocrine Bioscience Celgene Corporation Faron Pharmaceuticals Juno Therapeutics, Inc. Sobi |
Century Therapeutics Kite Pharma MorphoSys AG Sobi |
None | None | 11/29/2023 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Michael Haddadin MD | None | None | None | None | 04/23/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 12/04/2023 |
| Nitin Jain MD | AbbVie, Inc. Adaptive Biotechnologies ADC Therapeutics AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Carna Biosciences Cellectis Dialectic Therapeutics Eli Lilly and Company Fate Therapeutics Genentech, Inc. Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP KisoJi Medisix MingSight Newave Novalgen Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmacyclics Precision Biosciences Sana Biotechnology Takeda Pharmaceuticals North America, Inc. TransThera Sciences |
AbbVie, Inc. Adaptive Biotechnologies AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma |
None | None | 04/23/2024 |
| Brian Jonas PhD,MD | AbbVie, Inc. Amgen Inc. Aptose AROG Biomea Fusion Bristol Myers Squibb Celgene Corporation Forma Forty Seven, Inc. Genentech, Inc. Gilead Sciences, Inc. GlycoMimetics, Inc. Hanmi Immune-Onc Jazz Pharmaceuticals Inc. Kymera Loxo Pfizer Inc. Pharmacyclics Treadwell |
AbbVie, Inc. Bristol Myers Squibb Gilead Sciences, Inc. Kura Oncology, Inc. Rigel Syndax |
None | None | 02/01/2024 |
| Suzanne Kirby MD | None | None | None | None | 12/10/2023 |
| Michaela Liedtke MD | AbbVie, Inc. Allogene Biomea Bristol Myers Squibb Caelum Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP SeaGen |
AbbVie, Inc. Bristol Myers Squibb Nexcella |
None | None | 01/07/2024 |
| Mark Litzow MD | AbbVie, Inc. Actinium Amgen Inc. Astellas Pharma US, Inc. BeiGene Biosight Pluristem sanofi-aventis U.S. Syndax |
Amgen Inc. Jazz Pharmaceuticals Inc. |
Amgen Inc. BeiGene |
None | 01/21/2024 |
| Aaron Logan PhD,MPhil,MD | Amgen Inc. Autolus Kadmon Kite Pharma Talaris |
AbbVie, Inc. Actinium Amgen Inc. Pfizer Inc. sanofi-aventis U.S. |
None | None | 10/02/2023 |
| Meixiao Long PhD,MD | Xencor INC. | None | None | None | 04/22/2024 |
| Selina Luger MD | Biosight Kura Oncology, Inc. Marker Therapeutics |
AbbVie, Inc. Amgen Inc. Bristol Myers Squibb Novartis Pharmaceuticals Corporation |
None | None | 10/09/2023 |
| James Mangan PhD,MD | Amgen Inc. GlycoMimetics, Inc. Jazz Pharmaceuticals Inc. Merck & Co., Inc. |
Autolus Gilead Sciences, Inc. Jazz Pharmaceuticals Inc. Kura Oncology, Inc. Rigel Pharma Shoreline Bioscienceds |
None | None | 01/08/2024 |
| Stephanie Massaro MD,MPH | None | None | None | None | 11/29/2023 |
| Ryan Mattison MD | None | None | None | None | 04/17/2024 |
| Priyanka Nanjireddy MBBS | NA | NA | NA | NA | Pending |
| Olalekan Oluwole MD,MBBS,MPH | Kite Pharma | AbbVie, Inc. Allogene Autolus Beigene Caribou Gilead Sciences, Inc. Kite Pharma Nektar Therapeutics |
ADC Therapeutics | None | 12/31/2023 |
| Jae Park MD | Affyimmune Autolus Fate Therapeutics Genentech, Inc. Incyte Corporation Kite Pharma PeproMene Bio Servier Takeda Pharmaceuticals North America, Inc. |
Allogene Amgen Inc. Artiva Biotherapeutics Autolus Be Biopharma BeiGene Curocel Kite Pharma Pfizer Inc. Servier Sobi Takeda Pharmaceuticals North America, Inc. |
None | None | 06/20/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Sravanti Rangaraju MD | None | None | None | None | 03/22/2024 |
| Caner Saygin MD | None | None | None | None | 03/12/2024 |
| Marc Schwartz MD | None | None | Jazz Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation |
None | 06/12/2023 |
| Bijal Shah MD | AstraZeneca Pharmaceuticals LP Autolus Jazz Pharmaceuticals Inc. Kite Pharma Pepromene Bio Precision Biosciences Servier |
Adaptive Biotechnologies Amgen Inc. Deciphera Pharmaceuticals, Inc. Eli Lilly and Company Kite Pharma Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | 05/23/2023 |
| Paul Shami MD | Amgen Inc. Aptevo Chimeric Chimerix Ono. Pfizer Inc. |
Daiichi- Sankyo Co. | None | JSK Therapeutics | 11/07/2023 |
| Katie Stehman PA-C,MMS | None | None | None | None | 03/11/2024 |
| Samantha Tamburro OCN,RN,BSN | None | None | None | None | 04/24/2024 |
| Benjamin Tomlinson MD | None | Bristol Myers Squibb | None | None | 04/10/2024 |
| Eunice Wang MD | AbbVie, Inc. Arog Pharmaceuticals Astellas Pharma US, Inc. Biomea Cellectis Gilead Sciences, Inc. ImmunoGen, Inc. Incyte Corporation Kura Oncology, Inc. Pfizer Inc. Schrodinger Ing REG SHS Sumitomo Pharma Oncology Syros Pharmaceuticals Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Blueprint Medicines ImmunoGen, Inc. Kite Pharma Qiagen Rigel Schrodinger Ing REG SHS Syndax |
Astellas Pharma US, Inc. Dava Oncology Pfizer Inc. |
None | 03/29/2024 |
| Jonathan Webster MD | Servier | Amgen Inc. Jazz Pharmaceuticals Inc. Servier |
None | None | 01/12/2024 |